Manufactures and markets soft gelatin capsules and other dosage forms for the pharmaceutical and nutraceutical industries.
Procaps Group S.A. operates as a global leader in the development, production, and distribution of pharmaceutical solutions. With a rich history dating back to 1977, the company formulates, manufactures, and markets a diverse range of branded prescription drugs across multiple therapeutic categories. These include feminine care, pain relief, skin care, digestive health, cardiology, vision care, central nervous system disorders, and respiratory ailments.
In addition to its extensive portfolio of prescription medications, Procaps Group S.A. offers a comprehensive selection of over-the-counter (OTC) consumer healthcare products. These span approximately eight therapeutic areas, encompassing gastrointestinal treatments, skin care solutions, cough and cold remedies, analgesics, urological products, as well as vitamins, minerals, and dietary supplements. The company's commitment to enhancing health extends to providing innovative solutions such as blood glucose meters, telemonitoring products, oral anti-diabetics, cosmeceuticals, and insulin delivery systems.
Moreover, Procaps Group S.A. provides specialized contract drug development and manufacturing services to third-party pharmaceutical companies. Leveraging its expertise in soft gelatin capsule technologies, the company supports the production and delivery of high-quality pharmaceutical products worldwide. Headquartered in Luxembourg, Procaps Group S.A. continues to drive innovation and expand its global footprint in the healthcare industry.